Literature DB >> 5021967

Method for accelerated identification of arboviruses after inoculation of mice.

T S David-West.   

Abstract

Sequential titration of infective virus and complement-fixing antigen in brain and liver of suckling mice infected with the following virus strains-Dugbe (a new arbovirus), Congo (related to Crimean hemorrhagic fever virus), yellow fever, dengue 1 and dengue 2-showed a progressive increase in titer after infection. High titers of both infective virus and complement-fixing antigen were demonstrated long before the mice showed clinical signs of infection. It is suggested that earlier isolation and identification of arboviruses from clinical and field specimens can be made if serological tests are done before mice are moribund.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5021967      PMCID: PMC380366          DOI: 10.1128/am.23.3.437-440.1972

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  6 in total

1.  Relationship between strains of Crimean haemorrhagic fever and Congo viruses.

Authors:  M P Chumakov; S E Smirnova; E A Tkachenko
Journal:  Acta Virol       Date:  1970-01       Impact factor: 1.162

2.  Dugbe (DUG) strain. AR 1792.

Authors: 
Journal:  Am J Trop Med Hyg       Date:  1970-11       Impact factor: 2.345

3.  Organ distribution of infectivity and complement-fixing antigen with two Nigerian arboviruses.

Authors:  T S David-West
Journal:  Br J Exp Pathol       Date:  1970-06

4.  Antigenic similarity between the virus causing Crimean hemorrhagic fever and Congo virus.

Authors:  J Casals
Journal:  Proc Soc Exp Biol Med       Date:  1969-05

5.  Yellow fever virus infection. A correlation of complement-fixing antigen with histopathology.

Authors:  T S David-West; J A Smith
Journal:  Br J Exp Pathol       Date:  1971-04

6.  The use of adjuvant and sarcoma 180 cells in the production of mouse hyperimmune ascitic fluids to arboviruses.

Authors:  E S Tikasingh; L Spence; W G Downs
Journal:  Am J Trop Med Hyg       Date:  1966-03       Impact factor: 2.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.